A major shift is underway in pharmaceutical manufacturing as companies move toward hybrid cloud infrastructure, advanced analytics, and digital quality systems. Speaking on the industry's evolving landscape, Mike Hennessy Jr. of MJH Life Sciences highlighted how hybrid cloud architectures, statistical